Pharmacokinetics of paracetamol in calf plasma and saliva;Farmakokinetyka paracetamolu w osoczu krwi i ślinie ciela̧t

Medycyna Weterynaryjna

Volumn 62, Issue 6, 2006, Pages 686-689

  Grochowina, Beata ^a   Janus, Krzysztof ^a  

^a Zwierza̧t AR ^*  (Poland)

Author keywords

Paracetamol; Pharmacokinetics; Plasma; Saliva

Indexed keywords

ANIMALIA;

EID: 33745642705     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adithan C., Danda D., Swaminathan R. P., Indhiresan J., Shashidran C. H., Bapna S. J., Chandrasekar S.: Effect of diabetes mellitus on salivary paracetamol elimination. Clin. Exp. Pharmacol. Physiol. 1998, 15, 466-471.
2. Adzu B., Garba M., Haruna A., Maman M., Wambebe C., Gamaniel K.: Effect of niprisan on single oral dose pharmacokinetics of paracetamol in rats. Eur. J. Drug Metab. Pharmacokinet. 2001, 26, 201-204.
3. Ali B. H., Cheng Z., Hadrami G., Bashir A. K., McKellar Q. A.: Comparative pharmacokinetics of paracetamol (acetaminophen) and its sulphate and glucuronide metabolites in desert camels and goats. J. Vet. Pharmacol. Ther. 1996, 19, 238-244.
4. Al-Obaidy S. S., Li W., McKiernan P. J., Glasgow J. F. T., Millership J.: Paracetamol and its metabolites in urine, plasma and saliva of children with liver disease. J. Biomed. Pharm. Anal. 1995, 24, 1033-1039.
5. Anderson B.: Acetaminophen analgesia in infants. Anesth. Analg. 2001, 93, 1626-1627.
6. Babalola C. P., Oladimeji F. A., Femi-Oyewo M. N.: Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians. West. Afr. J. Med. 2004, 23, 10-14.
7. Bailie M. B., Federowicz D. A., Dolce K., Kahn C., Mico B. A., Landi M. S.: Pharmacokinetics of acetaminophen, vancomycin and antipyrine in the Hanford miniature swine. Drug. Metab. Disp. 1987, 15, 729-730.
8. Bannwarth B., Pehourcq F., Lagrange F., Malaga M., Maury S., Palisson M., Bars M.: Single and multiple dose pharmacokinetic of acetaminophen (paracetamol). J. Rheumatol. 2001, 28, 182-184.
9. Dominguez A., Medine R., Hurtado M.: Bioequivalence study of paracetamol tablets: in vitro - in vivo correlation. Drug. Dev. Ind. Pharm. 2000, 26, 821-828.
10. Flouvat B., Leneveu A., Fitoussi S., Delhotal-Landes B., Gendron A.: Bioequivalence study comparing a new paracetamol solution for injection and paracetamol after single intravenous infusion in healthy subjects. Int. J. Clin. Pharmacol. Ther. 2004, 42, 50-57.
11. Janus K., Antoszek J.: The effect of sex and age on caffeine pharmacokinetics in cattle. Res. Vet. Sci. 2000, 69, 33-37.
12. Janus K., Baranow-Baranowski S., Jakubowska D.: Trials to assessment of hepatic biotransformation rate in calves on the basis of the rate of antipyrine elimination from saliva. Arch. Vet. Pol. 1991, 31, 65-71.
13. Janus K., Grochowina B., Antoszek J., Suszycki S., Muszczynski Z.: The effect of food or water deprivation on paracetamol pharmacokinetics in calves. J. Vet. Pharmacol. Ther. 2003, 26, 291-296.
14. Kawalek J. C., El-Said K. R.: Maturational development of drug metabolizing enzymes in sheep. Am. J. Vet. Res. 1990, 51, 2044-2050.
15. Kearns G. L., Reed M. D.: Clinical pharmacokinetics in infants and children, a reppraisal. Clin. Pharmacokinet. 1999, 17, 29-52.
16. Lakin K. M., Zorian E. W., Kac M. M., Aleksandrowa G. M., Efremowa G. N.: Opredelenie soderżania lekarstvennych vescestv v sline v kliniceskich i eksperimentalnych issledovaniach farmakokinetiki. Farmakol. Toksikol. 1997, 50, 93-97.
17. Li X. D., Xia S. Q., He P., Hun J., Wu M. C.: Conjugation metabolism of acetaminophen and bilirubin in extrahepatic tissues of rats. Life Sci. 2004, 74, 1307-1315.
18. Linday L. A., Greenblatt D. J., Warren M. P., Harmatz J. S., De Cresce R., Ciralese C., Le Duc B. W.: Changes in salivary antipyrine pharmacokinetic during adolescence, correlated with age, hormonal levels and Tanner stage. Dev. Pharmacol. Ther. 2002, 16, 194-200.
19. Loft S., Haxholdt O., Dossing M.: Antipyrine clearance in children from single saliva samples. Br. J. Clin. Pharmacol. 1995, 19, 698-705.
20. McNamara P. J., Burgio D., Yoo S. D.: Pharmacokinetics of acetaminophen, antipyrine and salicylic acid in the lactating and nursing rabbit, with model predictions of milk to serum concentration ratios and neonatal dose. Toxicol. Appl. Pharmacol. 1999, 109, 149-160.
21. Meffin P. J., Wiliams R. L., Blaschke T. F., Rowland M.: Application of salivary concentration data to pharmacokinetic studies with antipyrine. J. Pharm. Sci. 1997, 66, 135-141.
22. Monshouwer M., Witkamp R. F., Pijpers A., Verheijden J. H. M., van Miert A. S.: Dose-dependent pharmacokinetic interaction between antipyrine and paracetamol in vivo and in vitro when administered as a cocktail in pig. Xenobiotica 1994, 24, 347-355.
23. Monshouwer M., Witkamp R. F., Nijmeijer S. M., Pijpers A., Verheijden J. H. M., van Miert A. S. J. P. A. M.: Selective effects of bacterial infection on the hepatic clearances of caffeine, antipyrine, paracetamol and indocyanine green in the pig. Xenobiotica 1995, 25, 491-499.
24. Mucklow J. C.: The use of saliva in therapeutic drug monitoring. Ther. Drug. Monit. 1992, 4, 229-234.
25. Muir N., Nichols J. D., Stillings M. R., Sykes S.: Comparative bioavailability of aspirin and paracetamol following single dose administration of soluble and plain tablets. Curr. Med. Res. Opin. 1997, 13, 491-500.
26. Plewka A., Zielińska-Psuja B., Kowalówka-Zawieja J., Nowaczyk-Dura G., Plewka D., Wiaderkiewicz A., Kamiński M., Orłowski J.: Influence of acetaminophen and trichloroethylene on liver cytochrome P-450-dependent monooxygenase system. Acta Bioch. Pol. 2000, 47, 1129-1136.
27. Posti J.: Drug concentration in plasma and saliva - physiological and phamacokinetic examination. Pharm. Acta Helv. 1999, 54, 191-199.
28. Routh J. J., Shane N. A., Arredonde E. G., Paul W. D.: Determination of N-acetyl-p-aminophenol in plasma. Clin. Chem. 1968, 9, 882-889.
29. Sawada T., Sako K., Fukui M., Jokohama S., Hayashi M.: A new index the bioavailability of acetaminophen. Int. J. Pharm. 2003, 265, 55-63.
30. Vesell E. S., Passananti G. T., Glenwright P. A., Dvorchik B. H.: Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva and urine. Clin. Pharmacol. Ther. 1995, 18, 259-272.
31. Vital-Durand D., Piolat C., Soucheleau J., Baltassat P., Brazier J. L.: Pharmacocinetique de le' antipyrine. Comparaison des concentration totales, libres et salivaires. Therapie 1998, 43, 263-266.
32. Welch R. M., De Angelis R. L., Wingfield M., Farmer T. W.: Elimination of antipyrine from saliva as a measure of metabolism in man. Clin. Pharmacol. Ther. 1995, 18, 249-258.
33. Zielińska E.: Paracetamol, [w:] Adamska-Dyniewska H. (red.): Terapia monitorowana. DWN, Łódź 1994, 269-276.
34. Zuidema J., Van Ginneken C. A.: Clearance concept in salivary drug excretion. Part II. Pharm. Acta Helv. 1993, 136-153, 1993.